BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Tris Pharma, Inc. Expands U.S. Ops, Plans to Create 75-100 New Jobs


10/19/2012 7:29:20 AM

While pharmaceutical companies continue to shutter facilities throughout central New Jersey, one firm has launched an aggressive effort to expand its footprint in the area. The Cranbury property will house Tris Pharma's manufacturing arm, as well as its research and development operations in the future. (Matrix Development Corp.) To accommodate a spike in manufacturing activity at its South Brunswick headquarters, drug maker Tris Pharma Inc. recently leased a 103,350-square-foot warehouse in Cranbury, though an executive said the company projects to grow out of the new facility within three years. "We've been looking on and off for new space in the last couple of years … as we've grown to have roughly 200 employees. But since we recently received FDA approval for a very meaningful product that we think will equate to another 75 to 100 jobs, we decided it was time to expand," said Peter Ciano, vice president of corporate development at Tris Pharma. "Though our growth all depends on what drug approvals we get — since you could be approved for the cure for cancer worth billions of dollars, or the ninth generic of penicillin worth $400 — I think if we continue the way we're going, three years from now, we'll have at least 400 employees." In addition to housing Tris Pharma's 70 current manufacturing and distribution workers, the Cranbury facility will be modified over time to accommodate the firm's research and development arm, since the space ultimately will hold 150 employees in both fields, Ciano said.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES